Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal
The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy.
8 Nov 12:38 · NY Times
Pfizer to buy Metsera for $13 billion, capping bidding war
The Metsera deal is about winning the obesity drugs' market that’s expected to reach US$100 billion by 2030. Read more at straitstimes.com. Read more at straitstimes.com.
8 Nov 06:02 · The Straits Times
Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk
Pfizer has signed a deal to purchase Metsera Inc., an obesity drugmaker in the development stage, after winning a bidding war against Novo Nordisk.
8 Nov 09:35 · The Seattle Times
last updated on 9 Nov 00:56